Fungemia by yeasts in Brazil: Occurrence and phenotypic study of strains isolated at the Public Hospital, Botucatu, Säo Paulo

Journal de Mycologie Medicale

Volumn 15, Issue 1, 2005, Pages 13-21

  Ruiz, L S ^a   Sugizaki, M F ^b   Montelli, A C ^b   Matsumoto, F E ^a   Pires, M F C ^c   Da Silva, B C M ^a   Silva, E H ^a   Gandra, R F ^a   Goncalves Da Silva E ^a   Auler, M E ^a   Paula, C R ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^c INSTITUTO ADOLFO LUTZ   (Brazil)

Author keywords

"Killer" toxins; Candida spp.; Exoenzymes; Fungemia

Indexed keywords

FUNGAL ENZYME; PHOSPHOLIPASE; PROTEINASE; VIRULENCE FACTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BIOTYPE; BLOOD CULTURE; BRAZIL; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; CHILD; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FUNGAL STRAIN; FUNGEMIA; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; HUMAN; MALE; PHENOTYPE; PUBLIC HOSPITAL; TAXONOMY; YEAST;

CANDIDA; CANDIDA ALBICANS; CANDIDA PARAPSILOSIS; FUNGI;

EID: 27644570228     PISSN: 11565233     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mycmed.2004.12.002     Document Type: Article

References (46)

1. Abi-Said D, Anaissie E, Uzun O, Road I, Pinzcowski H, Vartivarian S. The epidemiology of hematogeneous candidiasis caused by different Candida species. Clin Infect Dis 1997;24:1122-8.
2. Araujo MRE, Colombo AL. Infeccoes fungicas hospitalates. In: Manual de Microbiologia Clinica Aplicada ao Controle de Infecção Hospitalar. APECIH; 1998. p. 36-40.
3. Benjamin DK, Poole C, Steinbach WJ, Rowen JL, Walsh TJ. Neonatal candidemia and end-organ damage: a critical appraisae of the literature using meta-analityc techniques. Pediatrics 2003;112:634-40.
4. Bevan EA, Markower M. In: The physiological basis of the "killer" character in yeast. 21st Int. Congress. Genetics. 1963. p. 202-3 Abstract).
5. Bodey PG. Candidiasis-pathogenesis, diagnosis and treatment, second ed. Texas Raven Press; 1992.
6. Branchini ML, Pfaller MA, Rhine-Chalberg J, Frempong T, Isenberg HD. Genotypic variation and slime production among blood and catheter isolates of Candida parapsilosis. J Clin Microbiol 1994;32:452-6.
7. Candido RC, Fischman O, Zaror L, Ito IX. The differentiation of Candida albicans strains by the killer system. Rev Soc Bras Med Trop 1995;28:321-4.
8. Chapman RL. Candida infections in the neonate. Curr Opin Pediatr 2003;15:97-102.
9. Clancy CJ, Ghannoum MA, Nguyen MH. In: 36th Annu. Meet. Infect. Dis. Soc. Am. 1998. p. 317 Abstract.
10. Colombo AL, Nucci M, Salomão R, Branchini MLM, Richtmann R, Derossi A, et al. High rate of non-albicans candidemia in Brazilian tertiary care hospitals. Diagn Microbiol Infect Dis 1999;34:281-6.
11. Colombo AL, Guimaraes T. Epidemiologia das infeccoes hematogenicas por Candida spp. Rev Soc Bras Med Trop 2003;36:599-607.
12. Germain GS, Laverdière M, Pelletier R, Bourgault AM, Libman M, Lemieux C. Prevalence and antifungal susceptibility of 442 Candida isolates from blood and other normally sterile sites: results of a 2-year (1996-1998) multicenter surveillance study in Quebec, Canada. J Clin Microbiol 2001;39:949-53.
13. Ghannoum MA. Potential role of phospholipases in virulence and fungal pathgenesis. Clin Microbiol Rev 2000;13: 122-43.
14. Girmenia C, Martino P, De Bernardes F, Gentile G, Boccanera M, Monaco M, et al. Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis 1996;23:506-14.
15. Hube B. Possible role of secreted proteinases in Candida albicans infections. Rev Iberoam Micol 1998;15:65-8.
16. Ibrahim AS, Mirbord F, Filler SG, Banno Y, Cole GT, Kitajima Y, et al. Evidence implicating phospholipase as a virulence factor of Candida albicans. Infect Immun 1995; 63:1993-8.
17. Kao AS, Brandi ME, Pruit WR, Conn LA, Prkins BA, Stephens DS, et al. The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis 1999;29:164-70.
18. Krcméry Jr. V, Kovacicová G. The Slovak Fungaemia Study Group. Longitudinal 10-year prospective survey of fungemia in Slovak Republic: trends in etiology in 310 episodes. Diagn Microbiol Infect Dis 2000;36:7-11.
19. Krcméry V, Laho L, Huttova M, Ondrusova A, Kralynski K, Pevalova L, et al. Aetiology, antifungal susceptibility, risk factors and outcome in 201 fungaemic children: data from a 12-year prospective national study from Slovakia. J Med Microbiol 2002;51:10-116.
20. Kurtzman CP, Fell JW. The Yeasts: A Taxonomic Study. New York. 1998.
21. Lacaz CS, Porto E, Martins JEC. Micologia Medica, ninth ed. São Paulo Sarvier; 2002.
22. Levin AS, Costa SF, Mussi NS, Basso M, Sinto SI, Machado C, et al. Candida parapsilosis fungemia associated with implantable and semi-implantable central venous catheters and the hands of healthcare workers. Diagn Microbiol Infect Dis 1998;30:243-9.
23. Maffei CML, Paula CR, Mazzocato TS, Franceschini S. Phenotype and genotype and C. albicans strains delayed from pregnant women with recurrent vaginitis. Mycopathologia 1997;137:87-94.
24. Matsumoto FE, Gandra RF, Ruiz LS, Auler ME, Marques SAV, Pires MFC, et al. Yeasts isolated from blood and catheter in children from a Public Hospital of São Paulo, Brazil. Mycopathologia 2001;154:63-9.
25. Morace G, Archibucci C, Sestito M, Polonelli M. Strain differentiation of pathogenic yeast by the killer system. Mycopathologia 1984;84:81-5.
26. Oliveira EE, Silva SC, Soares AJ, Attux C, Cruvinel B, Silva MRR. "Killer" toxin sensitivity and production of enzymes by Candida albicans isolated from the oral mucosa of patients with cancer. Rev Soc Bras Med Trop 1998;31:523-7.
27. C.R. Paula, F.E. Matsumoto, T.A. Melo, Possible catheter-related infections in a Public Children's Hospital of São Paulo, Brazil. ASM Conference on Candida and Candidiasis, 1999a. Abstract, Charleston, South Carolina, pp. 35.
28. Paula CR, Sampaio MCC, Birman EG, Siqueira AM. Oral yeasts in patients with bucal cancer before and during radiotherapy. Mycopathologia 1990;112:119-24.
29. Pfaller MA, Jones RN, Messer SA, Edmond MB, Wenzel RP. The Scope Participant Group. National surveillance of nosocomial bloodstream infections due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE program. Diagn Microbiol Infect Dis 1998;39:121-9.
30. Pfaller MA, Diekema DJ, Jones RN, Sader HS, Fluit AC, Hollis RJ, et al. International surveillance of bloodstream infection due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program. J Clin Microbiol 2001;39:3254-9.
31. Price MF, Wilkinson ID, Gentry LO. Plate methods for detection of phospholipase activity in Candida albicans. Sabouraudia 1982;20:15-20.
32. Polonelli L, Archibusacci C, Sestito M, Morace G. "Killer" system: a simple method for differentiating Candida albicans. J Clin Microbiol 1983;17:774-80.
33. Rangel-Frausto MS, Wiblin T, Blunberg HM, Saiman L, Patterson J, Rinaldi M, et al., Nemis Study Group. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstreams infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units. Clin Infect Dis 1999;29:253-8.
34. Reef SE, Lasker BA, Butcher DS, et al. Nonperinatal nososcomial transmission of Candida albicans in a neonatal intensive care unit: prospective study. J Clin Microbiol 1998;32:1255-9.
35. Rodriguez-Tudela JL, Cuenca-Estrella M. Fungemia by yeast: a multicenter study in Spain. Rev Clin Esp 1999;199: 356-61.
36. Rüchel R. Proteinases of pathogenic fungi. Mycoses 1999; 42(Suppl. 1):48-52.
37. Rüchel R, Tgegeler R, Trost M. A comparison of secretory proteinase from different strains of Candida albicans. Saboraudia 1982;20:233-44.
38. Saiman L, Ludington E, Pfaller M, et al. Risk factors for candidemia in neonatal intensive care unit patients. Pediatr Infect Dis 2000;19:319-24.
39. Sanchez V, Vasquez JA, Barth-Jones D, Dembry L, Sobel JD, Zervos MJ. Nosocomial acquisition of Candida parapsilosis: an epidemiologic study. Am J Med 1993;94:577-82.
40. M.R.R. Silva, Variabilidade fenotipica e genotipica de amostras de Candida albicans isoladas da mucosa bucal de pacientes com AIDS. Ph.D. thesis. Instituto de Ciências Biomedicas H-USP, Sào Paulo, 1999.
41. Silveira FRX, Birman EG, Paula CR, Batista JM. Proteinase and phospholipase activity of Candida albicans isolated from oral mucosa of healthy carriers (smokers and nonsmokers). Rev Iber Micol 1993; 10:105-8.
42. Sugizaki MF, Rhoden CR, Bombonat DM, Montelli AC, Martinson ME, Lopes CAM. Prevalence and in vitro antifungal susceptibility of Candida spp. isalated from clinical specimens in São Paulo, Brazil. Rev Iberoam Micol 1998;15:16-8.
43. Tresoldi AT, Branchini MLM, Moreira Filho DC, Padoveneze MC, Dantas SPE, Reginato L, et al. Relative frequency of nosocomial microorgansim at Unicamp University Hospital from 1987 to 1994. Rev Inst Med Trop 1997;39:333-6.
44. Wey SB, Mori M, Pfaller MA, Woolson RF, Wenzel RP. Risk factors for hospital-acquired candidemia. A matched case-control study. Arch Intern Med 1998;149:2349-53.
45. Wingard JR. Importance of Candida species other than C. albicans as pathogens in oncology patients. Clin Infect Dis 1995;20:115-25.
46. Zanon U, et al. Frequência e mortalidade das infecções hospitalares em neonatologia e pediatria. ABP Supl Arq Bras Med 1992;66:20-3.